Showing 10,001 - 10,020 results of 28,834 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', query time: 0.89s Refine Results
  1. 10001

    The top 10 hub targets. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  2. 10002

    Original images for blots and gels requirements. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  3. 10003

    The top 10 active ingredients. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  4. 10004
  5. 10005

    The flow chart. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  6. 10006

    The active ingredients in RB-HMM. by Lefei Yu (12274846)

    Published 2025
    “…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
  7. 10007

    Physiologic values. by Hiroki Iwata (2434012)

    Published 2023
    “…The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (<i>P</i> < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, <i>P</i> = 0.999). …”
  8. 10008

    Early mobilization of critically ill patients in the intensive care unit: A systematic review and meta-analysis by Lan Zhang (90951)

    Published 2019
    “…</p><p>Conclusions</p><p>Early mobilization appears to decrease the incidence of ICU-AW, improve the functional capacity, and increase the number of ventilator-free days and the discharged-to-home rate for patients with a critical illness in the ICU setting.…”
  9. 10009

    Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial by Brian E. Lacy (776932)

    Published 2015
    “…Approximately one-third of linaclotide patients (each group) had ≥50% mean decrease from baseline in abdominal bloating vs. 18% of placebo patients (<i>P</i><0.01). …”
  10. 10010
  11. 10011
  12. 10012

    AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

    Published 2025
    “…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”
  13. 10013
  14. 10014
  15. 10015
  16. 10016
  17. 10017
  18. 10018

    Diversity and Composition of Demersal Fishes along a Depth Gradient Assessed by Baited Remote Underwater Stereo-Video by Vincent Zintzen (129134)

    Published 2012
    “…Species richness peaked in shallow depths, followed by a decrease beyond 100 m to a stable average value from 700 to 1200 m. …”
  19. 10019
  20. 10020

    A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan by Uzma Shamsi (8345664)

    Published 2020
    “…</p><p>Results</p><p>Compared to patients with sufficient serum vitamin D (>30 ng/ml), women with serum vitamin D deficiency (<20ng/ml), had a higher risk of breast cancer (OR = 1.65, 95%CI: 1.10, 2.50). …”